Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2021 Financial Results and Provide Business Update
Pressure BioSciences, Inc. (OTCQB:PBIO) will host a teleconference on April 5, 2022, at 4:30 PM ET to discuss its Fourth Quarter and Fiscal Year 2021 financial results and provide a business update.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pressure BioSciences, Inc. (OTCQB:PBIO) will host a teleconference on April 5, 2022, at 4:30 PM ET to discuss its Fourth Quarter and Fiscal Year 2021 financial results and provide a business update. The call will be available live and through replay for 30 days afterward. PBI's innovative pressure-based solutions, including its patented Pressure Cycling Technology (PCT) and the new Ultra Shear Technology (UST), are aimed at various sectors, enhancing capabilities in biomarker discovery, drug development, and food preservation.
Positive
- Recent acquisition of BaroFold technology opens entry into the bio-pharma contract services market.
- Launch of Ultra Shear Technology (UST) for stable nanoemulsions and improved shelf-life for liquid foods.
Negative
- None.
Details
News Market Reaction – PBIO
The recorded move for PBIO in the trading session of this news was +12.87%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call Scheduled for Tuesday, April 5 at 4:30pm ET
SOUTH EASTON, MA / ACCESSWIRE / April 1, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2021 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company's website) approximately one day after the teleconference.
The teleconference will include a Company presentation followed by a Question & Answer period.
Date: Tuesday, April 5, 2022. Time: 4:30 PM Eastern Time (ET).
To attend this teleconference, live by telephone: Dial-in: (888) 506-0062 (North America); (973) 528-0011 (International). Verbal Access Code: 648452 (or say Pressure BioSciences Conference Call)
For those unable to participate in the live teleconference, a replay will be available beginning Wednesday, April 6, 2022. The replay will be accessible via telephone and the Company's website for 30 days.
Replay Number: (877) 481-4010 (North America); (919) 882-2331 (Int'l); Replay Passcode: 45153.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Our primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
For more information about PBI and this press release, please click on the following website link:
http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.
Press Contacts:
Richard T. Schumacher, President & CEO (T) 508-230-1828
John B. Hollister, Director of Marketing and Sales (F) 508 230-1829
Jeffrey N. Peterson, Chairman of the Board (T) 650-812-8121
SOURCE: Pressure BioSciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/695621/Pressure-BioSciences-Inc-to-Discuss-Fourth-Quarter-and-Fiscal-Year-2021-Financial-Results-and-Provide-Business-Update
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.